國家衛生研究院 NHRI:Item 3990099045/8822

NHRI > National Institute of Cancer Research > Wun-Shaing Wayne Chang > Conference Papers/Meeting Abstract > Item 3990099045/8822

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/8822

Title:	Characterization of novel alpha-ketoamide derivatives as potent inhibitors against cathepsin S induced by acidic extracellular pH in pancreatic cancer cells
Other Titles:	Characterization of novel α-ketoamide derivatives as potent inhibitors against cathepsin S induced by acidic extracellular pH in pancreatic cancer cells
Authors:	Chang, WSW;Chang, TY;Wu, TC;Liao, CY;Lin, CC
Contributors:	National Institute of Cancer Research
Abstract:	Extracellular acidification is known to be a driving force in pancreatic cancer growth and metastasis. Thus, manipulation of acidic peritumoral pH or blockage of key proteins stimulated by acidic extracellular microenvironment may offer considerable potential for pancreatic cancer therapy. Cathepsin S, also known as CTSS or CatS, is a critical proteolytic enzyme found to be up-regulated in malignant cells and secreted into the extracellular milieu to degrade surrounding matrix components. By examining the effect of low pH (6.7) on various pancreatic tumor cell lines, we detected a consistently increased CTSS expression associated with augmented cell migration and invasion. Other features such as CTSS-mediated proteolysis and ECM degradation were also observed under mildly acidic condition. Based on these findings, we designed and synthesized some new small molecules bearing an α-ketoamide warhead to evaluate their ability to inhibit CTSS. Kinetic study revealed these compound inhibitors possess very low Ki values and high specificity against target CTSS enzyme. Further in vitro and in vivo analyses demonstrated these agents not only could protect fibronectin from CTSS-mediated degradation but also induce tumor cell autophagy under extracellular acidification. Together these results indicate the potential of α-ketoamide derivatives as antitumor agents against pancreatic cancer.
Date:	2014-10
Relation:	Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 4982.
Link to:	http://dx.doi.org/10.1158/1538-7445.am2014-4982
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0008-5472&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000349910203441
Appears in Collections:	[Wun-Shaing Wayne Chang] Conference Papers/Meeting Abstract

Files in This Item:

There are no files associated with this item.

Loading...